Search results
Novavax Stock Just Tripled. Is It Too Late to Buy?
Motley Fool via Yahoo Finance· 1 month agoAfter losing more than 90% of its value from a peak back in 2021, Novavax (NASDAQ: NVAX) stock has finally taken off. The biotech soared 190% in two...
Novavax Stock May Soar 379%, According to Wall Street. Is the Stock a Buy Right Now?
Motley Fool via Yahoo Finance· 5 months agoNovavax (NASDAQ: NVAX) soared more than 2,700% early in the pandemic as investors bet on its ability...
1 Wall Street Analyst Thinks Novavax Stock Is Going to $10. Is It a Sell?
Motley Fool via Yahoo Finance· 1 month agoNovavax (NASDAQ: NVAX) took a turn in the investor spotlight in early May, when the vaccine...
Has Novavax Just Solved Its Biggest Problem?
Motley Fool via Yahoo Finance· 4 months agoMany investors have seen Novavax (NASDAQ: NVAX) as a promising recovery story ever since the biotech launched a plan to cut costs to better match the...
Is It Too Late to Buy Novavax Stock?
Motley Fool via Yahoo Finance· 1 week agoNovavax (NASDAQ: NVAX) stock is suddenly a buy again this year, with its stock price more than tripling since the start of 2024. Some positive...
Is This the Telltale Sign to Sell Novavax Stock?
Motley Fool· 1 year agoUnfortunately, Novavax (NASDAQ: NVAX) hasn't had great timing. The company was late to the party in winning authorizations for its COVID-19 vaccine,...
Novavax Just Dropped a Bombshell on Investors: Even Management Is Questioning Its Future
Motley Fool· 1 year agoNovavax (NASDAQ: NVAX) faces an uncertain future ahead as the need for COVID-19 vaccines diminishes....
Better Recovery Story Buy: Novavax vs. Teladoc
Motley Fool via Yahoo Finance· 5 months agoEverybody loves a good recovery story. You can get in on a promising company, with a potentially bright future ahead, but at a terrific price. And that...
Novavax's Revenue Could Fall Even More -- and It's Actually Good News
Motley Fool· 2 years agoPick your favorite of these adjectives, and it will definitely apply to Novavax's (NASDAQ: NVAX) second-quarter update. What's more, Novavax slashed its full-year revenue guidance. Unsurprisingly ...
Some Breather For Novavax's COVID-19 Vaccine, Inks Multibillion-Dollar Deal With Sanofi And Erases...
Benzinga via Yahoo Finance· 1 month agoFriday, Novavax Inc (NASDAQ: NVAX) entered a co-exclusive licensing agreement with Sanofi SA...
